For nearly 20 years, the Bioprocess Technology Group has been tracking the supply and demand for biopharmaceutical manufacturing and will present the manufacturing landscape from 2007 to today, revealing BDO’s visionary projections for 2029. Dawn will highlight some of the manufacturing trends that have reshaped the capacity landscape to our current state and explore the potential impact of currently developing events on both supply and demand within the bioTRAK forecast. Key themes include the shifting dynamics of capacity ownership and accessibility, the industry’s appetite for outsourcing and how geography may influence manufacturing. For nearly 20 years, the Bioprocess Technology Group has been tracking the supply and demand for biopharmaceutical manufacturing capacity. This presentation will include and overview of the manufacturing landscape from 2007 to today and will reveal BDO’s projections for the industry’s supply and demand for manufacturing capacity for the next several years, through 2029. Dawn will highlight the trends that have reshaped the manufacturing capacity landscape to our current state and explore the potential impact of currently developing events on both supply and demand within the bioTRAK forecast. Key themes include the shifting dynamics of capacity ownership and accessibility, the industry’s appetite for outsourcing, and the potential impact of geography on manufacturing trends.